会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • MOUNTING SYSTEM FOR MOBILE DEVICES
    • 移动设备安装系统
    • US20160001708A1
    • 2016-01-07
    • US14788706
    • 2015-06-30
    • Omar Syed MAHMOODAdam Seth WEISINGER
    • Omar Syed MAHMOODAdam Seth WEISINGER
    • B60R7/04
    • B60R11/02B60R2011/0059B60R2011/0075
    • A passenger seat mounting system adaptable for various and changing mobile technology is provided. The universal mounting system has an enclosure and a universal bracket assembly for securing to the various and changing mobile technology. The enclosure defines an enclosure cavity for said mobile technology, wherein the universal bracket assembly operatively engages the mobile technology through rear cutouts of the enclosure so that all three components are removably secured. The universal mounting system may be pivotally connected to supporting legs that are adapted to slide into standard head rest holes of a seat body. As the universal bracket assembly is adjustable, so are the varieties of mobile technology that can be universally mounted.
    • 提供适用于各种不断变化的移动技术的乘客座椅安装系统。 通用安装系统具有外壳和通用支架组件,用于固定各种不断变化的移动技术。 外壳限定了用于所述移动技术的外壳,其中通用托架组件通过外壳的后切口可操作地接合移动技术,使得所有三个部件可移除地固定。 通用安装系统可以枢转地连接到适于滑入座椅主体的标准头枕孔的支撑腿。 随着通用支架总成的调整,移动技术的种类也可以普及。
    • 8. 发明申请
    • Drug delivery device
    • 给药装置
    • US20050187607A1
    • 2005-08-25
    • US10783727
    • 2004-02-20
    • Adil AkhtarSyed Mahmood
    • Adil AkhtarSyed Mahmood
    • A61F2/00A61F2/06
    • A61F2/07A61F2/90A61F2002/072A61F2002/075A61F2250/0067
    • A medical device for drug delivery is provided which includes a stent structure and a biologically active structure attached to the stent structure. The biologically active structure is comprised of a plurality of layers, including a first layer having a first biologically active compound, such as an anti-proliferative, cytostatic or cytotoxic drug, for delivery at a first target site, such as the vascular tissue; a second layer having a second biologically active compound, such as a growth factor, for delivery into the arterial lumen and capable of promoting engraftment and differentiation of hematopoietic stem cells and/or endothelial progenitor cells at a second site of myocardial injury; and a third, middle layer which is substantially or selectively impermeable to both the first and second biologically active compounds.
    • 提供了用于药物递送的医疗装置,其包括附接到支架结构的支架结构和生物活性结构。 生物活性结构由多个层组成,包括具有第一生物活性化合物的第一层,例如抗增殖,细胞抑制或细胞毒性药物,用于在第一靶位点如血管组织递送; 具有第二生物活性化合物(例如生长因子)的第二层,用于递送至动脉腔并且能够促进造血干细胞和/或内皮祖细胞在心肌损伤的第二部位的移植和分化; 以及第三中间层,其基本上或选择性地不渗透第一和第二生物活性化合物。